Skip to main content
OpenTrials
Completed

NCT Number: NCT04829903

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Treated With Insulin Adolescent Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pediatric Obesity Signs and Symptoms

Age range

12 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zainab Khan

Lahore, Punjab Province, Pakistan

About this study

To observe the efficacy, effect on glycemic control, impact on BMI and incidence of adverse effects of Dulaglutide and to compare it to Liraglutide in individuals aged thirteen to eighteen who have Type 2 diabetes mellitus and are obese.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 Diabetes Mellitus
  • Obese
  • Taking metformin
  • Male or female

Exclusion criteria

  • Non obese
  • Not taking metformin
  • Taking other injectable diabetic medications

Treatment and study plan

Dulaglutide

Drug

Dulaglutide injections

Other names: Group DUL

liraglutide

Drug

Liraglutide injections

Other names: Group LIR

Primary outcomes

  1. Glycemic level

    Time frame: 24 weeks for the duration of the study

    HbA1c

  2. BMI

    Time frame: 24 weeks for the duration of the study

    BMI measurements using weight and height measurements (anthropometric)

  3. Adverse effects

    Time frame: 24 weeks for the duration of the study

    Recording of adverse effects

Sponsors and collaborators

Lead sponsor

Corporacion Parc Tauli

Other

Registry information

Official study title

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 2, 2021
Registry last updated
Mar 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.